Drug Trial Radar · NCT06215859
Study of MR-107A-02 for the Treatment of Acute Postoperative Pain Following Herniorrhaphy
Last checked: Nov 20, 2026Latest source record: Feb 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
579
Actual
Start
Dec 29, 2023
Primary completion
Jan 31, 2025
Study completion Mar 12, 2025
Sponsor
- Lead sponsor
- Viatris Specialty LLCIndustry
- Sponsor type
- Industry
- Collaborators
- Mylan Specialty, LP
- First posted
- Jan 22, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
MR-107A-02 is being studied to investigate its efficacy and safety for treatment of acute pain after herniorrhaphy.
Conditions
- Acute Pain
- Post Operative Pain
- Pain
Interventions
MR-107A-02Drug
tablet
TramadolDrug
over-encapsulated tablet
PlaceboDrug
over-encapsulated tablet and/or tablet
HerniorrhaphyProcedure
Unilateral open inguinal herniorrhaphy with mesh under general anesthesia
Primary outcomes
What the sponsor says the trial is designed to measure.
- Summed Pain Intensity Difference (SPID) for MR-107A-02 versus placebo.Time frame: 48 hours after randomization
Locations
18 sites in 1 country. Site status is shown where the registry gives one.
Investigator site 210
Sheffield, Alabama
Investigator site 213
Phoenix, Arizona
Investigator site 202
Anaheim, California
Investigator site 222
Bakersfield, California
Investigator site 208
Riverside, California
Investigator site 211
Miami, Florida
Investigator site 206
Tampa, Florida
Investigator site 207
Atlanta, Georgia
Investigator site 205
Wichita, Kansas
Investigator site 212
Bellaire, Texas
Investigator site 215
Carrollton, Texas
Investigator site 204
Houston, Texas
Investigator site 216
McAllen, Texas
Investigator site 219
San Antonio, Texas
Investigator site 203
San Antonio, Texas
Investigator site 214
San Antonio, Texas
Investigator site 201
Salt Lake City, Utah
Investigator site 224
Eau Claire, Wisconsin
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.